Clinical Trials in Deventer, Overijssel
6 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 2
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Malignant Neoplasm
Merck Sharp & Dohme LLC130 enrolled13 locationsNCT07252739
Recruiting
Phase 3
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Triple Negative Breast Neoplasms
Merck Sharp & Dohme LLC1,000 enrolled250 locationsNCT06841354
Recruiting
Phase 4
Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study)
Prostate CancerPain Cancer
Deventer Ziekenhuis29 enrolled1 locationNCT07001709
Recruiting
Not Applicable
Improving Social Cognition and Social Behaviour in Various Brain Disorders
Brain TumorStrokeMultiple Sclerosis
University Medical Center Groningen84 enrolled2 locationsNCT06330298
Recruiting
Phase 3
PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy
Prostate CancerCancer Recurrence
University Medical Center Groningen538 enrolled13 locationsNCT04642027
Recruiting
Not Applicable
Organ Preservation in Rectal Cancer: Contact X-ray Brachytherapy vs Extending the Waiting Interval and Local Excision
Quality of LifeRectal CancerLocally Advanced Rectal Carcinoma+1 more
The Netherlands Cancer Institute168 enrolled7 locationsNCT05772923